Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Sarcoma 1Lymphoma 1Lymphedema 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Neoplasms 1Fibrosis 1Deglutition Disorders 1Congenital Abnormalities 1

Interventions

Pentoxifylline 3Tocopherols 2tremelimumab 1ruxolitinib 1maltodextrin 1durvalumab 1atezolizumab 1Vitamin E 1Sunitinib 1Standard of Care 1Specimen Handling 1Simvastatin 1Pravastatin 1Physical Therapy Modalities 1Pharmaceutical Preparations 1Magnetic Resonance Spectroscopy 1Losartan 1Liver Transplantation 1Ketoprofen 1Hyperbaric Oxygenation 1Bevacizumab 1Amino Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fibrosis × Pravastatin × Clear all
NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

M.D. Anderson Cancer Center

Phase 2 Recruiting
250 enrolled
Head & Neck

Fibrosis, Head and Neck Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡